Primary central nervous system marginal zone B‐cell lymphoma arising from the dural meninges: A case report and review of literature

Primary central nervous system (CNS) marginal zone B‐cell lymphoma (MZBCL) arising from the dural meninges is a rare but indolent disease. This malignancy can present in various ways, hence making it difficult to diagnose. Biopsy results dictate an appropriate treatment plan, which commonly consists...

Full description

Saved in:
Bibliographic Details
Published inClinical case reports Vol. 8; no. 3; pp. 491 - 497
Main Authors Lopetegui‐Lia, Nerea, Delasos, Lukas, Asad, Syed Daniyal, Kumar, Manish, Harrison, Jonathan S.
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.03.2020
John Wiley and Sons Inc
Wiley
Subjects
Biomarkers
Bone marrow
Case Report
Case Reports
central nervous system lymphomas
dural lymphoma
Hemorrhage
Lymphoma
Magnetic resonance imaging
marginal zone B‐cell lymphoma
meningeal lymphoma
Nervous system
Patients
Radiation therapy
Sarcoidosis
Tumors
marginal zone B‐cell lymphoma
dural lymphoma
meningeal lymphoma
central nervous system lymphomas
Online AccessGet full text

Cover

More Information
Summary:Primary central nervous system (CNS) marginal zone B‐cell lymphoma (MZBCL) arising from the dural meninges is a rare but indolent disease. This malignancy can present in various ways, hence making it difficult to diagnose. Biopsy results dictate an appropriate treatment plan, which commonly consists of a combination of surgical resection, whole brain radiotherapy and systemic therapy. Primary central nervous system (CNS) marginal zone B‐cell lymphoma (MZBCL) arising from the dural meninges is a rare but indolent disease. This malignancy can present in various ways, hence making it difficult to diagnose. Biopsy results dictate an appropriate treatment plan, which commonly consists of a combination of surgical resection, whole brain radiotherapy and systemic therapy.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.2680